These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 16467455

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. DY-9760e, a novel calmodulin inhibitor, exhibits cardioprotective effects in the ischemic heart.
    Fukunaga K, Han F, Shioda N, Moriguchi S, Kasahara J, Shirasaki Y.
    Cardiovasc Drug Rev; 2006; 24(2):88-100. PubMed ID: 16961723
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Microsphere embolism-induced endothelial nitric oxide synthase expression mediates disruption of the blood-brain barrier in rat brain.
    Han F, Shirasaki Y, Fukunaga K.
    J Neurochem; 2006 Oct; 99(1):97-106. PubMed ID: 16987238
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. DY-9760e, a novel calmodulin antagonist, reduces infarction after permanent focal cerebral ischemia in rats.
    Sato T, Takamori H, Shirasaki Y.
    Pharmacology; 2004 May; 71(1):38-45. PubMed ID: 15051921
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of neuronal nitric oxide synthase activity by 3-[2-[4-(3-chloro-2-methylphenyl)- 1-piperazinyl]ethyl]-5, 6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e), a novel neuroprotective agent, in vitro and in cultured neuroblastoma cells in situ.
    Fukunaga K, Ohmitsu M, Miyamoto E, Sato T, Sugimura M, Uchida T, Shirasaki Y.
    Biochem Pharmacol; 2000 Sep 01; 60(5):693-9. PubMed ID: 10927028
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum S-100b protein as a biomarker for the assessment of neuroprotectants.
    Shirasaki Y, Edo N, Sato T.
    Brain Res; 2004 Sep 24; 1021(2):159-66. PubMed ID: 15342263
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities.
    Lu YM, Shioda N, Han F, Kamata A, Shirasaki Y, Qin ZH, Fukunaga K.
    Cardiovasc Ther; 2009 Sep 24; 27(1):17-27. PubMed ID: 19207476
    [Abstract] [Full Text] [Related]

  • 18. DY-9760e, a novel calmodulin antagonist with cytoprotective action.
    Sugimura M, Sato T, Nakayama W, Morishima Y, Fukunaga K, Omitsu M, Miyamoto E, Shirasaki Y.
    Eur J Pharmacol; 1997 Oct 01; 336(1):99-106. PubMed ID: 9384259
    [Abstract] [Full Text] [Related]

  • 19. Calpastatin overexpression attenuates amyloid-beta-peptide toxicity in differentiated PC12 cells.
    Vaisid T, Barnoy S, Kosower NS.
    Neuroscience; 2008 Oct 28; 156(4):921-31. PubMed ID: 18786620
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.